CVE-2018-1821

Public Exploit

Description

IBM Operational Decision Management 8.5, 8.6, 8.7, 8.8, and 8.9 is vulnerable to a XML External Entity Injection (XXE) attack when processing XML data. A remote attacker could exploit this vulnerability to expose sensitive information or consume memory resources. IBM X-Force ID: 150170.

Category

7.1
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 30.59% Top 5%
Vendor Advisory ibmcloud.com Vendor Advisory ibm.com
Affected: IBM Operational Decision Management
Published at:
Updated at:

References

Link Tags
https://www.ibm.com/support/docview.wss?uid=ibm10744149 vendor advisory
http://www.securityfocus.com/bid/106325 vdb entry third party advisory
https://www.exploit-db.com/exploits/46017/ exploit vdb entry third party advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/150170 vdb entry vendor advisory

Frequently Asked Questions

What is the severity of CVE-2018-1821?
CVE-2018-1821 has been scored as a high severity vulnerability.
How to fix CVE-2018-1821?
To fix CVE-2018-1821, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-1821 being actively exploited in the wild?
It is possible that CVE-2018-1821 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~31% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2018-1821?
CVE-2018-1821 affects IBM Operational Decision Management.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.